Frontier Zdravlje celebrates 70 years of successful business
Frontier Zdravlje ceremoniously marked a significant milestone – seven decades of dedication to innovation, trust, and quality. The celebration, held on Friday, November 24, brought together more than 350 guests, including our business partners, collaborators, and representatives of institutions who, along with our employees, reminisced about the extensive history of Zdravlje.
Frontier Zdravlje expands EU presence with PazoFront® authorization in Bulgaria
Frontier Zdravlje has received another Marketing Authorisation in the CEE issued by the Bulgarian Drug Agency for PazoFront® 200mg and 400mg, film-coated tablets (INN: pazopanib). PazoFront’s active substance (pazopanib) is a protein kinase inhibitor that works by preventing the activity of proteins involved in the growth and spread of cancer cells.
CEO’s Announcement on the Biotech Future Forum in Belgrade
To mark this week’s second Biotech Future Forum in Belgrade, our CEO, Kiren L. Naidoo, reaffirms Frontier Zdravlje’s commitment to building the biotechnology industry in Serbia. Through valuable partnerships with the Government of the Republic of Serbia, academia, and leading international partners, Frontier Zdravlje are set to lead the biotechnology industry in the region across critical areas such as next-generation vaccines, cell & gene therapies – all domestically produced and intended to serve patients locally and abroad.
Frontier Biopharma Signs Landmark MoU with SK Bioscience and Government of Serbia to Establish a European Vaccines Development and Manufacturing Hub in Serbia
Frontier Biopharma Limited today announced the signing of a Memorandum of Understanding (“MoU”) between the Government of Serbia, SK Bioscience and Frontier Biopharma to establish a vaccines development and manufacturing hub in Serbia.
Vishal Kumar Gupta appointed as Group Chief Financial Officer (CFO)
We are pleased to announce that Mr. Vishal Kumar Gupta has joined our leadership team as Group Chief Financial Officer, reporting to Kiren Naidoo (CEO).
Latest Project: The signing of a license agreement with the MPP
Frontier Zdravlje announces the signing of a license agreement with the Medicines Patent Pool (MPP) for a generic version of nirmatrelvir, the novel oral COVID-19 antiviral medicine, developed by Pfizer, which is administered in combination with low dose ritonavir.
Cape Town-based biotechnology company, Afrigen, appoints new board chair
We are very proud to announce that our Chairman and Board Member, Mr. Levent Selamoglu has been appointed as Chairman of Afrigen Biologics. Afrigen is a leading biotechnology company based in Cape Town, South Africa. The company is focused on product development, bulk adjuvant manufacturing and distribution of key biologicals to address unmet healthcare needs. In 2020 Afrigen was selected by World Health Organisation (WHO) and Medicines Patent Pool (MPP) as a mRNA Technology Transfer hub for the supply of mRNA-based products for low and middle income countries.
Frontier Zdravlje and Adalvo Sign Licensing & Supply Agreement for Central & Eastern Europe
Frontier Zdravlje and Adalvo are pleased to announce their collaboration in several therapeutic areas for the markets of Central and Eastern Europe and the Balkans. Over the next months and years, this collaboration will extend Frontier’s commercial and therapeutic footprint with a basket of more than 30 molecules from Adalvo’s advanced development pipeline in high value chronic and niche areas, targeting early-launch and first-generic opportunities where available.
Frontier Zdravlje Awarded for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia
We are proud to announce that Frontier Zdravlje has received the Award for Successful Business in 2022 by the Chamber of Commerce and Industry of Serbia. At the Ceremony held on 9 December, the Chamber of Commerce and Industry of Serbia awarded the traditional Annual Awards to the most successful companies in Serbia.
Frontier Zdravlje at “Serbia Business Run” in Belgrade
Frontier Zdravlje participated for the first time on September 29. at the great “Serbia Business Run“ in Belgrade. This manifestation, which aims to promote healthy lifestyles and running as a great way of recreation for the modern working person, is a series of 5 km business races, which are held in the largest business centers of Serbia and represent the largest sports and corporate event in our country.